Sách chuyên đề : Bệnh lý dị ứng

Thông tin tài liệu

Hội Phổi Pháp - Việt

1 Hội Phổi Pháp-Việt Sách chuyên đề - Bệnh lý dị ứng    BS. Michèle RAFFARD  Trung tâm Y khoa -  - 75015 PARIS mraffard@free.fr 2 Hội Phổi Pháp-Việt Sách chuyên đề - Bệnh lý dị ứng Chương 1   các b (BS. Michèle RAFFARD) M  :    (1). Nghiên cu ISAAC   : ISAAC International Study of Asthma and Allergy in Childhood (Nghiên  -   o  o  o  o  o       3000    7-8 t  -  các câu h.  (2).   3 Hội Phổi Pháp-Việt Sách chuyên đề - Bệnh lý dị ứng    o  o  Bao nhiêu  Không   > 12 o     o  o  o Khò khè trong hay sau ho? o  o     I hen. o  o  o  o  o  o   Ít khi  u không ?    o Có phát ban? o   > 6 tháng  o     o   o  o  o  4 Hội Phổi Pháp-Việt Sách chuyên đề - Bệnh lý dị ứng        -  -  Alternaria -  - : ADN -   o   Sanh non    o    o  o      hà N   o   -      Giai (4) -                  nguyên nhân. 5 Hội Phổi Pháp-Việt Sách chuyên đề - Bệnh lý dị ứng Hen và viêm mũi > 25% với các nước nói tiếng Anh, nhưng <10% cho các nước đang phát triển.                   Hình 1  - Lancet 1998. 6 Hội Phổi Pháp-Việt Sách chuyên đề - Bệnh lý dị ứng Hình 2 -14 Lancet 1998. Giai (5)    ,   (6)   (7) -   -                   21,5%   (8)       :19,7%> Tonga :16,2%>Niue   Pháp   :10,4%> Tân Calédonie :8,2%> Samoa :5,8%  khác  (9)      -   3,2 %  1,39 % (10) -  Hen :11% (11) - ISAAC   (12) -      2,4 % -  (14),    7 Hội Phổi Pháp-Việt Sách chuyên đề - Bệnh lý dị ứng - m ký sinh trùng trong phân,  -  o Con mt = 14,4%  quan h c vm ra o Gián ng vc ung. - Lâm sàng  -    Singapore (15) -  -                      - ) Các loi mnh  Blomia tropicalis  Dermatophagoides farinae  Dermatophagoides pteronyssinus  Austroglycyphagus malaysiensis  Sturnophagoides brasiliensis  Tirophagus putrescentiae Malaysia Kuala Lumpur (18)   - Theo dõi gi nghim vi 14 d nguyên - Chi là mt gián (43%). Thái Lan (19)   - Dermatophagoides pteronyssinus (67%) - Dermatophagoides farinae (62%) - Gián M: Periplaneta americana. (44%)   Blomia +   8 Hội Phổi Pháp-Việt Sách chuyên đề - Bệnh lý dị ứng Blomia tropicalis ở  Singapor và Bangkok (20)       Blomia             (Dermatophagoides farinae)   - D ng vi BT > DF  Singapor - D ng vi DF > BT  Bangkok Singapor (148), Jakarta (105), Chiang Mai (108), Bangkok (41), Mumbai (101) Jakarta : 57% > Singapour : 56% > Bangkok : 21% > Chiang Mai : 14% > Mumbai : 15% Blomia Tropicalis  %)  Thái Lan (21) Singapor (22) Malaysia(23) (24) Dermatophagoides ptreronyssinus 67 88 75 81 Dermatophagoides farinae 62 63 74 79 Blomia tropicalis 87  44 43 39  53 36  10 24 22  6 6 8  9 Hội Phổi Pháp-Việt Sách chuyên đề - Bệnh lý dị ứng Hình 3 -    (26) o  b o Nhiu b hen o ng hng m t va n nng o S tn ti giy vic ki o  ng hay không d ng là yu t  o Phn lt cp ca bng phi hp vi nhim virus      -    10 Hội Phổi Pháp-Việt Sách chuyên đề - Bệnh lý dị ứng  1. Ait-Khaled N. Allergy 2007;62:230. 2. Asher MI ISAAC:rationale and methods Eur Respi J 1995;8:483. 3. Phankingthongkum S. How do Thai children and adolescents describe asthma symptoms? Ped Allery Immunol 2002;13:119. 4. Etude ISAAC Lancet 1998;351:1225-3. 5. Weinmyar G et al. Atopic Sensitization and the International Variation of Asthma Symptom Prevalence in Children AJRCCM 2007;176:565-74. 6. Lee SL. Increasing prevalence of allergic rhinitis but not asthma among children in Hong Kong from 1995 to 2001 (Phase III ISAAC) Pediatr Allergy Immunol 2004;15:72-8. 7. N Ait-Khaled et al. Prevalence of symptoms of asthma, rhinitis and eczema in 13-14 year-old children in Africa. Allergy 2007;62:247-58. 8. Foliaki S et al Prevalence of symptoms of childhood asthma, allergic rhioconjunctivitis and eczema in the Pacific. Allergy 2007;62:259-64. 9. Pearce N et al. Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC).Thorax 2007 ;62 :758. 10. Linh P D et al. Congrès AFVP 1996. 11. Nguyen N A et al Congrès AFVP Ha Noi 2000. 12.  Ha Noi J All Clin Immunol 2004;637-44. 13. Sy DQ et al. Singapore Med J 2007;48:294-303. 14. C. Florh. Poor sanitation and helminth infection protect against skin sensitization in VN children : a cross-sectional study. J All Clin Immunol 2006;118:1305). 15. Chew FT . Sensitization to local dust mite fauna in Singapore. Allergy 1999;54:115;0). 16. Zhang L Prevalence and distribution of indoor allergens Clin Exp Allergy 1997;27:876. 17. Sy DQ, Thanh Binh MH, Quoc NT, Hung NV, Quynh Nhu DT, Bao NQ, Khiet LQ, Hai TD, Raffard M, Aelony Y, Homasson JP. Prevalence of asthma and asthmalike symptoms in Dalat highlands. Singapore Med J 2007;48:294-303. 18. Sam CK An investigation of aeroallergens affecting urban Malaysian asthmatics. Asian Pacific J Allergy Immunol 1998;16(1):17-20. 19. Kongpanichkul A et al. Allergen skin test reactivities among asthmatic Thai children. J Med Association Thailand 1997;80(2):69-75. 20. Angus AC. Patterns of allergic sensitization and cross-reactivity between BT and D.farinae. JACI.2002;109(sup1)S208. 21. Kongpanichkul A J Med Association Thailand 1997;80(2):69. 22. Zhang L et al. Clincal and Exper Allergy 1997;27:876-885. 23. Sam.Asian Paci J Allergy Immunol 1998;16(1):17-20. 24. Ji Tsai. Int Arch Allergy Immunol 1998;117:180-6. 25. Masoli M et al. The global burden on asthma Allergy 2004 ;59 :469-78 26. Bousquet J et al. ARIA Update. Allergy 2008;63 (Suppl 86). . Pháp-Việt Sách chuyên đề - Bệnh lý dị ứng  1. Ait-Khaled N. Allergy 2007;6 2:2 30. 2. Asher MI ISAAC:rationale and methods. 2 Hội Phổi Pháp-Việt Sách chuyên đề - Bệnh lý dị ứng Chương 1   các b (BS. Michèle RAFFARD)

Ngày đăng: 12/03/2013, 11:12

Xem thêm: Sách chuyên đề : Bệnh lý dị ứng, Sách chuyên đề : Bệnh lý dị ứng

Sách chuyên đề : Bệnh lý dị ứng

Thông tin tài liệu

Từ khóa liên quan

Tài liệu cùng người dùng

Tài liệu liên quan